Back

A deep cellular atlas of the human ventral substantia nigra in Parkinson's identifies a genetic and molecular overlap with Type 2 Diabetes

Volpato, V.; Menassa, D.; Sheshadri, P.; Giussani, S.; Rokicki, M.; Cardo, L. F.; Bafaloukou, M.; Schalkamp, A.-K.; Zaremba, A.; Monzon-Sandoval, J.; Vinh, N.-N.; Morgan, J.; Hu, M. T. M.; Miners, S.; Wade-Martins, R.; Sandor, C.; Parkkinen, L.; Webber, C.

2025-05-28 neurology
10.1101/2025.05.28.25328401 medRxiv
Show abstract

Parkinsons disease (PD) is a complex neurodegenerative disorder characterised by selective neuronal loss. We integrate deep full-length single-nuclei sequencing of the human substantia nigra with novel genome-wide association studies (GWAS) identifying genetic and cellular drivers of PD. Genetic risk converges on AGTR1+ dopaminergic neurons and perineuronal oligodendrocytes (pODCs), both reduced in PD, as well as oligodendrocyte precursor cells, enriched among disease-disrupted intercellular interactions. AGTR1+ neurons represent a metabolically stressed state, characterised by renin-angiotensin system (RAS) and MAPK activation, oxidative stress, and mitochondrial dysfunction, rather than a distinct subtype. AGTR1+ neurons and pODCs link PD risk to metabolic traits; in pODCs, this association reflects insulin resistance with downregulated PI3K-AKT signalling. GWAS of comorbid PD and type 2 diabetes (T2D) identifies loci in AGTR1 and TCF7L2, while AGTR1+ neurons specifically upregulate RAS and T2D drug targets. Familial PD genes associated to comorbid PD/T2D associate with non-Lewy body PD, stratifying disease mechanisms.

Matching journals

The top 3 journals account for 50% of the predicted probability mass.

50% of probability mass above

"Similar papers" are the closest papers from that journal in the model's embedding space. They show what the match is built on, but the ranking comes mostly from a classifier over the whole training set, not from these examples alone.